High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$29K
$29,643
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MGX |
Metagenomi Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-03-05 | $2,571 | S | Form 4 |
| MGX |
Metagenomi Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-05 | $2,530 | S | Form 4 |
|
MGX
S
Metagenomi Therapeutics, Inc.
Wein Matthew
• Officer • See Remarks
Sell to Cover
2026-03-05
$771
|
||||||
| MGX |
Metagenomi Therapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-05 | $771 | S | Form 4 |
| MGX |
Metagenomi, Inc.
|
CEO
Sell to Cover
|
2025-12-05 | $2,839 | S | Form 4 |
| MGX |
Metagenomi, Inc.
|
Director
Sell to Cover
|
2025-12-05 | $6,786 | S | Form 4 |
| MGX |
Metagenomi, Inc.
|
CFO
Sell to Cover
|
2025-12-05 | $2,793 | S | Form 4 |
| MGX |
Metagenomi, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-12-05 | $353 | S | Form 4 |
| MGX |
Metagenomi, Inc.
|
CEO
Sell to Cover
|
2025-09-05 | $2,900 | S | Form 4 |
| MGX |
Metagenomi, Inc.
|
Director
Sell to Cover
|
2025-09-05 | $4,889 | S | Form 4 |
| MGX |
Metagenomi, Inc.
|
CFO
Sell to Cover
|
2025-09-05 | $2,853 | S | Form 4 |
| MGX |
Metagenomi, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-09-05 | $360 | S | Form 4 |